MYELODYSPLASTIC SYNDROMES
Clinical trials for MYELODYSPLASTIC SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for High-Risk leukemia: interferon drug may keep cancer away after transplant
Disease control Not yet recruitingThis study tests whether the drug interferon-α can prevent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) from coming back in patients with a TP53 gene mutation who have already had a stem cell transplant. About 100 people aged 12-65 will receive interferon-α to s…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 28, 2026 21:35 UTC
-
Can patients safely stop Anti-Rejection drugs sooner after transplant?
Disease control Not yet recruitingThis study tests whether patients who receive a stem cell transplant for blood cancers can safely stop taking the immunosuppressive drug tacrolimus earlier than usual. About 50 participants will be enrolled to see if early cessation by day 88 is feasible and does not lead to seve…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC